AUG 10, 2026 · JOURNAL ARTICLE
Efficacy of atezolizumab in combination with carboplatin and etoposide in first-line therapy for advanced small cell lung cancer in real clinical practice: a retrospective single-center study
P a Herzen Journal of Oncology
Retrospective single-center cohort study confirming efficacy and safety outcomes of atezolizumab plus chemotherapy in advanced SCLC, replicating key endpoints from the pivotal IMpower133 trial in a real-world population.
Reported
Sample size58
Median age63.3 years
ECOG 2 performance status20.7%